Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-20-005787

President acquired 80,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MAUNEY DAVID M MD President 2020-01-29 Grant or award +80,500 275,778 D
Derivatives
MAUNEY DAVID M MD President 2020-01-29 Grant or award · Employee Stock Option (right to buy) +123,900 123,900 D
Loading xslF345X03/doc4.xml…